Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Core Viewpoint - Kiniksa Pharmaceuticals International, plc will host a conference call and live webcast to report its fourth quarter and full year 2025 financial results on February 24, 2026 [1]. Group 1: Conference Call Details - The conference call is scheduled for February 24, 2026, at 8:30 a.m. Eastern Time [1]. - A live webcast will be available on the company's website, and telephone participants can register to receive a confirmation email with access details [2]. - A replay of the event will be accessible on Kiniksa's website approximately 48 hours after the event [2]. Group 2: Company Overview - Kiniksa is a biopharmaceutical company focused on developing novel therapies for patients with debilitating diseases, particularly in cardiovascular indications [3]. - The company's portfolio is based on strong biological rationale or validated mechanisms, offering potential for differentiation in the market [3].